Belviq, the recently FDA approved drug for long term weight-loss, is now available at pharmacies and our offices.
We plan to use Belviq primarily as an adjunct to other well established combination medications we currently use. The rationale for this is that by itself Belviq is only modestly effective with a reported average weight loss of 7.9%. About 47% of patients lost 11 pounds or more and 22% lost 22 pounds or more.
However, patients who have been unable to to tolerate Topamax (Topiramate) and or Adipex (Phentermine) would be good candidates for a trial of Belviq.
Individual results may vary with treatment.